优化PCSK9抑制剂治疗:在临床实践中理解和管理非最佳的LDL-C反应
Filippo Giorgio Di Girolamo1, Lisa Pellin2, Chiara Roni1
1Pharmacy Unit, Cattinara University Hospital, Trieste, Italy.
European journal of internal medicine
|August 9, 2025
概括
蛋白转化酶亚提利辛/素9型抑制剂 (PCSK9-i) 显著降低了LDL-C,但一些患者表现出不理想的反应. 本综述详细介绍了反应不足的原因,并为有效的脂质管理提供了临床指导.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 脂质代谢 脂质代谢是什么
背景情况:
- 蛋白转化酶亚素/素9型抑制剂 (PCSK9-i) 对于降低LDL-C至关重要,特别是在高危心血管患者中.
- 尽管临床试验有效,但现实数据显示,有一部分患者在PCSK9-i治疗中无法实现最佳的LDL-C降低.
研究的目的:
- 探索PCSK9抑制剂对低最佳LDL-C反应的频率和潜在机制.
- 为临床医生提供一本用于识别和管理PCSK9-i反应不足的实用指南.
主要方法:
- 对PCSK9抑制剂疗效和患者反应现有文献的综述.
- 分析导致低于最佳的降脂效应的因素.
- 综合临床策略来解决反应不足的问题.
主要成果:
- 对PCSK9-i反应不足可能源于药物暴露不足 (例如,不坚持,注射技术差) 或生物因素限制有效性.
- 识别反应不足的原因是优化治疗结果的关键.
结论:
- 解决PCSK9-i反应不足需要采用多方面的方法,考虑患者相关和药物相关的因素.
- 在高风险人群中,有效管理不足反应对于持续降低心血管风险至关重要.
相关概念视频
Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
871
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
871
Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Cardiomyopathy V: Interprofessional Care
33
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33


